| scholarly article | Q13442814 |
| P2093 | author name string | Cullen BR | |
| Hauber J | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| 2 New M13 vectors for cloning | Q27861042 | ||
| Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS | Q28262859 | ||
| Nucleotide sequence of the AIDS virus, LAV | Q28286313 | ||
| Interactions between a DNA-binding transcription factor (COUP) and a non-DNA binding factor (S300-II) | Q28288709 | ||
| Improved Estimation of Secondary Structure in Ribonucleic Acids | Q29616525 | ||
| An inducible transcription factor activates expression of human immunodeficiency virus in T cells | Q29618434 | ||
| Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III. | Q34161762 | ||
| A second post-transcriptional trans-activator gene required for HTLV-III replication | Q34162178 | ||
| HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. | Q34186306 | ||
| Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events | Q34344850 | ||
| The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat | Q34564367 | ||
| Polymorphism of the 3' open reading frame of the virus associated with the acquired immune deficiency syndrome, human T-lymphotropic virus type III. | Q35564616 | ||
| Nudease-hypersensitive sites in the chromalin domain of the chicken lysozyme gene | Q35676704 | ||
| Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus | Q37412665 | ||
| Interaction between two transcriptional control sequences required for tumor-antigen-mediated simian virus 40 late gene expression | Q37553332 | ||
| Adenovirus promoters and E1A transactivation | Q39507235 | ||
| Regulation of inducible and tissue-specific gene expression | Q39656942 | ||
| DNAase I-hypersensitive sites of chromatin | Q40081637 | ||
| Chromatin | Q40130938 | ||
| Expression of the art/trs protein of HIV and study of its role in viral envelope synthesis | Q41886681 | ||
| Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. | Q43858457 | ||
| Human interleukin 2. | Q43867352 | ||
| The trans-activator gene of the human T cell lymphotropic virus type III is required for replication | Q44579665 | ||
| Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system | Q45029117 | ||
| Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein | Q45830211 | ||
| Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism | Q45830933 | ||
| Expression and characterization of the trans-activator of HTLV-III/LAV virus | Q45831293 | ||
| Complete nucleotide sequences of functional clones of the AIDS virus | Q45834378 | ||
| Regulation of AIDS virus expression | Q45836093 | ||
| Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). | Q45838520 | ||
| Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. | Q48365300 | ||
| Identification of a cellular transcription factor involved in E1A trans-activation | Q48366187 | ||
| Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro | Q48375884 | ||
| Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). | Q48381924 | ||
| Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. | Q54739833 | ||
| Alternative sets of DNase I-hypersensitive sites characterize the various functional states of the chicken lysozyme gene | Q59092573 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mutational analysis | Q1955810 |
| P304 | page(s) | 673-679 | |
| P577 | publication date | 1988-03-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat | |
| P478 | volume | 62 |
| Q24684723 | A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter |
| Q35833883 | A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses |
| Q64378953 | A region of basic amino-acid cluster in HIV-1 Tat protein is essential for trans-acting activity and nucleolar localization |
| Q39717672 | A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription |
| Q33662926 | A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat |
| Q34306796 | Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1 |
| Q40060891 | An adenosine at position 27 in the human immunodeficiency virus type 1 trans-activation response element is not critical for transcriptional or translational activation by Tat |
| Q41079020 | Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. |
| Q36831828 | Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats |
| Q36828521 | Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation |
| Q33834125 | Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis |
| Q36696760 | Bovine immunodeficiency-like virus encodes factors which trans activate the long terminal repeat |
| Q33795939 | Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator |
| Q28342742 | Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335 |
| Q41576182 | Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. |
| Q34160290 | Click dimers to target HIV TAR RNA conformation |
| Q24317451 | Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs |
| Q34671913 | Comparison of SIV and HIV-1 genomic RNA structures reveals impact of sequence evolution on conserved and non-conserved structural motifs |
| Q40454547 | Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. |
| Q33936851 | Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression |
| Q36798014 | Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein |
| Q36807977 | Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1. |
| Q35792991 | Detailed mutational analysis of TAR RNA: critical spacing between the bulge and loop recognition domains |
| Q40041542 | Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants |
| Q33815010 | Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. |
| Q33835531 | Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication |
| Q40041905 | Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1. |
| Q35835407 | Efficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure |
| Q36793376 | Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs |
| Q36687332 | Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat |
| Q37633114 | Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. |
| Q36831988 | Functional analysis of the Tat trans activator of human immunodeficiency virus type 2. |
| Q40116360 | Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader region. |
| Q36873530 | Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1. |
| Q38346354 | Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat |
| Q24655684 | Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat |
| Q37056955 | Genetic regulation of human immunodeficiency virus. |
| Q35937536 | HIV-1 Tat protein promotes formation of more-processive elongation complexes |
| Q41234955 | HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure |
| Q40407802 | Human T cell transcription factor GATA-3 stimulates HIV-1 expression |
| Q36798955 | Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line |
| Q38345116 | Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation |
| Q38293063 | Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication |
| Q36640831 | Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms |
| Q37633631 | Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. |
| Q33575002 | Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus |
| Q34311433 | Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA |
| Q40066797 | Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras |
| Q40046178 | Identification of transactivation-response sequences in the long terminal repeat of bovine immunodeficiency-like virus |
| Q35792284 | Identification of transcriptional suppressor proteins that bind to the negative regulatory element of the human immunodeficiency virus type 1 |
| Q35888626 | Inhibition of human immunodeficiency virus replication by the herpes simplex virus virion host shutoff protein |
| Q33930741 | Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators |
| Q28378556 | Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro |
| Q24671522 | Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator |
| Q38188271 | Life of psi: how full-length HIV-1 RNAs become packaged genomes in the viral particles |
| Q35403061 | Mechanism of action of regulatory proteins encoded by complex retroviruses |
| Q39820667 | Molecular biology and pathogenesis of animal lentivirus infections. |
| Q38320613 | Multiple positive and negative cis-acting elements that mediate transactivation by bel1 in the long terminal repeat of human foamy virus. |
| Q36831514 | Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity |
| Q36788071 | Multivalent Amino Sugars to Recognize Different TAR RNA Conformations. |
| Q24656004 | Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein |
| Q36804564 | Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein |
| Q36700611 | Mutational analysis of the equine infectious anemia virus Tat-responsive element |
| Q24682057 | Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly |
| Q39719048 | Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin |
| Q40043226 | Orientation-specific cis complementation by bulge- and loop-mutated human immunodeficiency virus type 1 TAR RNAs. |
| Q34523721 | Posttranscriptional m(6)A Editing of HIV-1 mRNAs Enhances Viral Gene Expression. |
| Q40066451 | Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts |
| Q47554842 | Production of HIV-1 vif mRNA Is Modulated by Natural Nucleotide Variations and SLSA1 RNA Structure in SA1D2prox Genomic Region |
| Q42735234 | Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. |
| Q39550188 | R region sequences in the long terminal repeat of a murine retrovirus specifically increase expression of unspliced RNAs. |
| Q39877972 | RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat. |
| Q36694541 | Rapid activation and subsequent down-regulation of the human immunodeficiency virus type 1 promoter in the presence of Tat: possible mechanisms contributing to latency |
| Q33961121 | Recognition of HIV TAR RNA by triazole linked neomycin dimers |
| Q24646216 | Regulation of human immunodeficiency virus env expression by the rev gene product |
| Q24645992 | Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat |
| Q42457052 | Sequences within the R region of the long terminal repeat activate basal transcription from the HIV-1 promoter. |
| Q39872155 | Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat |
| Q34284937 | Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region |
| Q36796119 | Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins |
| Q36802812 | Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence. |
| Q28547355 | Structure-Based Alignment and Consensus Secondary Structures for Three HIV-Related RNA Genomes |
| Q41238682 | TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes |
| Q24555668 | TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation |
| Q37059502 | Tat and Rev: positive modulators of human immunodeficiency virus gene expression |
| Q37594301 | Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA. |
| Q40628737 | The 0.3-kb fragment containing the R-U5-5'leader sequence of Friend murine leukemia virus influences the level of protein expression from spliced mRNA. |
| Q36698552 | The Bel-1 protein of human foamy virus activates human immunodeficiency virus type 1 gene expression via a novel DNA target site |
| Q38317126 | The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements |
| Q36831819 | The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. |
| Q34180644 | The bend in RNA created by the trans-activation response element bulge of human immunodeficiency virus is straightened by arginine and by Tat-derived peptide |
| Q36649447 | The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression. |
| Q40725617 | The genome of feline immunodeficiency virus. |
| Q36632734 | The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. |
| Q37548928 | The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA |
| Q34317298 | The same 50-kDa cellular protein binds to the negative regulatory elements of the interleukin 2 receptor alpha-chain gene and the human immunodeficiency virus type 1 long terminal repeat |
| Q39580918 | The secondary structure of the R region of a murine leukemia virus is important for stimulation of long terminal repeat-driven gene expression. |
| Q33567142 | Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells |
| Q40526004 | Transactivation of heterologous promoters by HIV-1 tat. |
| Q36797541 | Transcellular transactivation by the human immunodeficiency virus type 1 tat protein |
| Q35070466 | Transcriptional activity of the human immunodeficiency virus-1 LTR promoter in fission yeast Schizosaccharomyces pombe |
| Q36797785 | Transcriptional elongation by purified RNA polymerase II is blocked at the trans-activation-responsive region of human immunodeficiency virus type 1 in vitro |
| Q36828988 | Transcriptional initiation and postinitiation effects of murine leukemia virus long terminal repeat R-region sequences |
| Q34352999 | Transcriptional regulation of porcine endogenous retroviruses released from porcine and infected human cells by heterotrimeric protein complex NF-Y and impact of immunosuppressive drugs |
| Q39870080 | Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors. |
| Q36708965 | Translational control of retroviruses. |
| Q38330641 | Unusual structure of the human immunodeficiency virus type 1 trans-activation response element |
| Q33400343 | Yeast genetic analysis reveals the involvement of chromatin reassembly factors in repressing HIV-1 basal transcription |
Search more.